Guyer Charles Greg
EVP, Chief Technical Officer
Guyer Charles Greg has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Mar 19, 2026.
On the most recent filing, Guyer Charles Greg is listed as EVP, Chief Technical Officer at BIOMARIN PHARMACEUTICAL INC. Inside the rolling window, Guyer Charles Greg reported no open-market purchases and 1 open-market sale totaling $997K in BMRN.
Companies traded
Other insiders at BMRN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$997K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Guyer Charles Greg made?
Guyer Charles Greg has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Guyer Charles Greg trade?
Guyer Charles Greg has filed SEC Form 4 disclosures for 1 company, including BMRN.
When was Guyer Charles Greg's most recent SEC Form 4 filing?
Guyer Charles Greg's most recent SEC Form 4 filing on Tracefour is dated Mar 19, 2026.
What is Guyer Charles Greg's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Guyer Charles Greg is listed as EVP, Chief Technical Officer.
What is Guyer Charles Greg's total buy and sell value in the current window?
Inside the rolling retention window, Guyer Charles Greg bought $0 and sold $997K based on SEC Form 4 filings.
What was Guyer Charles Greg's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,486 BMRN shares on 2026-03-11, worth $997K, per SEC Form 4 filings.